Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.32 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.32 |
| ▸ | CASR | P41180 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28409176 | 0.87 | CA14 (0.41) | CA14HDAC1HDAC2HDAC6CASR | |
| SCHEMBL1688828 | 0.84 | CA14 (0.41) | CA14HDAC1HDAC2HDAC6CASR | |
| SCHEMBL7297469 | 0.83 | CA14 (0.38) | CA14HDAC1HDAC2HDAC6HDAC3 | |
| SCHEMBL4918504 | 0.80 | CA14 (0.37) | CA14HDAC1HDAC2HDAC6CASR | |
| SCHEMBL20262979 | 0.80 | CA14 (0.42) | CA14HDAC1HDAC2HDAC6HDAC3 | |
| SCHEMBL7117687 | 0.79 | CA14 (0.36) | CA14HDAC1HDAC2HDAC6 | |
| SCHEMBL1688812 | 0.78 | CA14 (0.38) | CA14HDAC1HDAC2HDAC6CASR | |
| SCHEMBL8696091 | 0.78 | CA14 (0.43) | CA14HDAC1HDAC2HDAC6CASR | |
| SCHEMBL1105464 | 0.77 | HDAC6 (0.34) | CA14HDAC1HDAC2HDAC6 | |
| SCHEMBL18116039 | 0.76 | CA14 (0.41) | CA14HDAC1HDAC2HDAC6CASR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8901353-B2 | Polyimide precursor, polyimide, and liquid crystal aligning agent | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2014-12-02 | — | — | US | disclosed |
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088888-A1 | POLYIMIDE PRECURSOR, POLYIMIDE, AND LIQUID CRYSTAL ALIGNING AGENT | PUF60, F13A1, F12 | CA14 1563/4885HDAC1 3429/4885HDAC2 3785/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.